Description
Gusacitinib is a dual inhibitor of SYK/JAK kinases.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Gusacitinib is a dual inhibitor of SYK/JAK kinases.
| Cas No. | 1425381-60-7 |
|---|---|
| Purity | ≥98% |
| Formula | C24H28N8O2 |
| Formula Wt. | 460.54 |
| IUPAC Name | 2-[1-[4-[4-(4-hydroxypiperidin-1-yl)anilino]-5-oxo-6H-pyrimido[4,5-d]pyridazin-2-yl]piperidin-4-yl]acetonitrile |
| Synonym | ASN-002, ASN002 |
| Appearance | Yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Montilla A, Gomez-Garcia F, Gomez-Arias P, et al. Scoping review on the use of drugs targeting JAK/STAT pathway in atopic dermatitis, vitiligo, and alopecia areata. Dermatol The (Heidelb). 2019 Dec;9(4):655-683. PMID: 31606872
Selective inhibitor of the delta isoform of PI3...
Piperazine; FIASMA, D2 antagonist, hERG K+ chan...
Saponin found in Dioscorea; Na+/K+ ATPase and C...
5-HT3 antagonist.
Macrolide lactone antibiotic.
Six-histidine peptide used for affinity column ...
GABA-A antagonist.
ROCK inhibitor.
Steroidal alkaloid found in Fritillaria; M2 mAC...
FXR agonist.
JAK2 inhibitor.
Endogenous peptide, involved in immune signalin...
principal metabolic product of COX-2
Caffeic acid derivative.
Triterpene saponin found in species of Panax.